Stocks
Allogene Therapeutics (ALLO) Cash US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Cash, bln rub | 588.9 | 1 032 | 809.5 | 576.5 | 448.7 | 384.9 | |||
| Changes by years, y/y, % | -18% | +75% | -22% | -29% | -22% | -9.1% | |||
Allogene Therapeutics. Cash, bln rub
Allogene Therapeutics. Cash, changes, %
Allogene Therapeutics (ALLO) Cash US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Cash, bln rub | 514.0 | 492.0 | 465.5 | 448.7 | 384.9 | 384.9 | ||
| Changes by years, y/y, % | +14% | +0% | -16% | -22% | -25% | |||
| Changes by quarters, q/q, % | -11% | -4% | -5% | -4% | -14% | |||
